The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.
." Its manufacturer, Novo Nordisk, says keeping supplies stable is a priority. The company also markets Ozempic to treat diabetes, which is a lower dose of semaglutide.
Her Aetna insurance plan covered the cost of the medication, but when she changed jobs last fall, her new insurance plan through Blue Cross and Blue Shield of Illinois denied coverage. She now works in a hospital ER registering patients, which requires her to sit most of the day. And, after a few months of not taking the drug, she has gained back 20 pounds."I'm very frustrated about the weight coming back on in so little time," Hamilton says.
, who treats Yolanda Hamilton. Kushner also serves on a Novo Nordisk medical advisory board, for which he receives an honoraria. Kushner's office is helping Hamilton appeal the insurance denial, but as she waits, she's worried that stopping the medication will also influence her blood pressure and blood sugar."She is at risk of having these conditions worsen with regain of weight," Kushner says.
"Unfortunately, being a new medication, it's one of those that is subject to the pricing of the manufacturer," Robinson says. "Some of the people who need it the most are unable to access it," Robinson says, pointing out that people with low incomes experience obesity at disproportionately higher rates.Black and Hispanic adults have higher rates of obesitySince Wegovy was approved by the FDA in 2021, some insurance plans have begun to cover the medication for people who meet the clinical prescribing guidelines.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
What it’s like to take the blockbuster drugs Ozempic and Wegovy, from severe side effects to losing 50 poundsTen people opened up to NBCNews about taking the blockbuster drugs Ozempic and Wegovy for weight loss, diabetes or other chronic health conditions — and they all described a wide variety of experiences.
Weiterlesen »
What it’s like to take Ozempic and Wegovy, from severe side effects to 50-pound lossesTen people taking the medications for weight loss, diabetes or other chronic health conditions described a wide range of experiences.
Weiterlesen »
Wegovy works. But here's what happens if you can't afford to keep taking the drugThe new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.
Weiterlesen »
Wegovy works. But here's what happens if you can't afford to keep taking the drugThe new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.
Weiterlesen »
Maybe adults should act more like children when it comes to fairnessI recently asked readers to weigh in on my column — subject line: My Thoughts.
Weiterlesen »
Artists Weigh In on the Battle Over NFT Creator RoyaltiesSmart contract-based NFT royalties have been embraced by independent artists as a much-needed protection, the perfect Web3 antidote to years of creator exploitation, but many issues remain with the reality of royalties. megdematteo weighs in:
Weiterlesen »